iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Shares Down 1.3% – Should You Sell?

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) shares traded down 1.3% during trading on Monday . The stock traded as low as $25.43 and last traded at $25.50. 1,121 shares traded hands during mid-day trading, an increase of 73% from the average session volume of 647 shares. The stock had previously closed at $25.83.

iShares Neuroscience and Healthcare ETF Stock Performance

The firm has a market capitalization of $3.83 million, a P/E ratio of 28.31 and a beta of 1.06. The stock has a fifty day moving average price of $26.68 and a two-hundred day moving average price of $25.58.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC acquired a new position in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent SEC filing.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.